Joseph A. Boystak
President & CEO
Brightwaters Capital, LLC
Joseph A. Boystak is founding president and chief executive officer of Brightwaters Capital, LLC, a private equity investment firm focused in life sciences, nanotechnology and clean technology. The firm focuses on acquiring early to late stage assets and building companies around specific technology themes or business strategies. Brightwaters Capital, through its affiliate Hudson/Brightwaters, a private merchant banking firm, provides strategic advice, capital raising, corporate partnering and mergers and acquisitions advice for its portfolio companies and select clients.
Previously, Mr. Boystak spent over 20 years working on Wall Street as an investment banker in the health care industry. Most recently, he was the founding managing director responsible for the global life sciences practice at Jefferies & Co. He previously served as the managing director and global head of health care at Tucker Anthony Sutro (now RBC Capital Markets) and Security Pacific Merchant Bank (now Bank of America Securities) and general partner of Trouver Capital Partners. He also was vice president and one of the founding investment bankers in Dean Witter Reynolds Health Care Group (now Morgan Stanley). During this time he was directly responsible for approximately $15 billion of financing and mergers and acquisitions transactions in the health care industry. These transactions included private placements, IPOs, follow-on offerings, convertible securities, high yield debt, bank credit facilities, tender offers, recapitalizations and restructurings for clients in health care services, medical devices, biotechnology, information technology, pharmaceuticals and REITs in the U.S. and international markets. He started his professional career with American Medical International (AMI:NYSE) as a recruit in the Chairman’s Program and was a member of the corporate development group, which was responsible for acquisition and development projects worldwide.
Mr. Boystak has been an invited speaker or faculty member on numerous health care-related topics for the following institutions: 3i; American College of Eye Surgeons; American Enterprise Institute; American Society for Aesthetic Plastic Surgery; BIOCOM–San Diego; California Orthopaedic Association; California Society for Healthcare Attorneys; Drug Delivery Partnerships; Fulcrum Information Services; Milken Institute Global Conference; the State of New Jersey’s Stem Cell Initiative; and UCLA’s Anderson School of Management. He has also authored articles in California Medicine and is listed in Strathmore’s Who’s Who 1999 for his accomplishments in health care finance.
He currently serves as founder/director of the following companies: Cardioceutics, Inc. (a private company spun out of UCLA and University of Colorado); NanoPacific Holdings, Inc. (a private company spun out of UCLA); WaterStyle Holdings, Inc. (a private company spun out of UCLA); VigilNet America LLC; and Exosome Diagnostics, Inc. (a private company spun out of Harvard University). He received his bachelor’s degree (cum laude) from Boston University, a master of health science degree from the Johns Hopkins Bloomberg School of Public Health and completed postgraduate study at the Wharton School.